[{"indications": "Indications\u00a0see notes above", "name": "FOLLITROPIN ALFA and BETA Follitropin alfa", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.5 Hypothalamic and pituitary hormones and anti-oestrogens", "6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens", "Anterior pituitary hormones", "Gonadotrophins", "FOLLITROPIN ALFA and BETA", "Follitropin alfa"], "cautions": "Cautions\u00a0acute porphyria (section 9.8.2)", "side-effects": "Side-effects\u00a0see under Human Menopausal Gonadotrophins", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/38658.htm", "doses": ["By subcutaneous or intramuscular injection, according to patient\u2019s response", "Name[Gonal-F\u00ae (Merck Serono) ] Injection, powder for reconstitution,\r\nfollitropin alfa. Net price 75-unit amp = \u00a321.02; 450\u00a0units/0.75\u00a0mL,\r\nmultidose vial = \u00a3126.10; 1050\u00a0units/1.75\u00a0mL, multidose vial = \u00a3294.22\r\n(all with solvent). For subcutaneous injection\nInjection, prefilled pen, follitropin\r\nalfa 600\u00a0units/mL, net price 0.5\u00a0mL (300\u00a0units) = \u00a394.00, 0.75\u00a0mL\r\n(450\u00a0units) = \u00a3141.00, 1.5\u00a0mL (900\u00a0units) = \u00a3282.00. For subcutaneous\r\ninjection"], "pregnancy": "Pregnancy\u00a0avoid"}, {"indications": "Indications\u00a0see notes above", "name": "FOLLITROPIN ALFA and BETA Follitropin alfa with lutropin alfa", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.5 Hypothalamic and pituitary hormones and anti-oestrogens", "6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens", "Anterior pituitary hormones", "Gonadotrophins", "FOLLITROPIN ALFA and BETA", "Follitropin alfa with lutropin alfa"], "cautions": "Cautions\u00a0acute porphyria (section 9.8.2)", "side-effects": "Side-effects\u00a0see under Human Menopausal Gonadotrophins", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/200062.htm", "doses": ["By subcutaneous or intramuscular injection, according to patient\u2019s response", "Name[Pergoveris\u00ae (Merck Serono) ] Injection, powder for reconstitution,\r\nfollitropin alfa 150\u00a0units (11\u00a0micrograms), lutropin alfa 75\u00a0units\r\n(3\u00a0micrograms), net price per vial (with solvent) = \u00a360.29. For subcutaneous\r\ninjectionElectrolytes: Na+<1\u00a0mmol/vial"], "pregnancy": "Pregnancy\u00a0avoid"}, {"indications": "Indications\u00a0see notes above", "name": "FOLLITROPIN ALFA and BETA Follitropin beta", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.5 Hypothalamic and pituitary hormones and anti-oestrogens", "6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens", "Anterior pituitary hormones", "Gonadotrophins", "FOLLITROPIN ALFA and BETA", "Follitropin beta"], "cautions": "Cautions\u00a0acute porphyria (section 9.8.2)", "side-effects": "Side-effects\u00a0see under Human Menopausal Gonadotrophins", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/56578.htm", "doses": ["By subcutaneous or intramuscular injection, according to patient\u2019s response", "Name[Puregon\u00ae (Organon) ] Injection, follitropin beta 100\u00a0units/mL,\r\nnet price 0.5-mL (50-unit) vial = \u00a318.03; 200\u00a0units/mL, 0.5-mL (100-unit)\r\nvial = \u00a336.06; 300\u00a0units/mL, 0.5-mL (150-unit) vial = \u00a350.62; 400\u00a0units/mL,\r\n0.5-mL (200-unit) vial = \u00a367.49; 0.36-mL (300-unit) cartridge = \u00a397.41,\r\n0.72-mL (600-unit) cartridge = \u00a3194.82, 1.08-mL (900-unit) cartridge\r\n= \u00a3292.23, (cartridges for use with Puregon\u00ae pen).\r\nFor subcutaneous (cartridges and vials) or intramuscular injection\r\n(vials)Excipients  may include neomycin and streptomycin"], "pregnancy": "Pregnancy\u00a0avoid"}, {"indications": "Indications\u00a0see notes above", "name": "FOLLITROPIN ALFA and BETA", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.5 Hypothalamic and pituitary hormones and anti-oestrogens", "6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens", "Anterior pituitary hormones", "Gonadotrophins"], "cautions": "Cautions\u00a0acute porphyria (section 9.8.2)", "side-effects": "Side-effects\u00a0see under Human Menopausal Gonadotrophins", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/38657.htm", "doses": ["By subcutaneous or intramuscular injection, according to patient\u2019s response"], "pregnancy": "Pregnancy\u00a0avoid"}]